Skip to main content
Equibles

Jain Global LLC

Position in HUMA — Humacyte, Inc.

CIK 2024579 NEW YORK, NY
Back to HUMA Full portfolio

Position in HUMA

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$89,355
+$51,493 QoQ
Shares Held
114,558
+190.8% QoQ
Ownership
0.041%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#47
of 163 holders
Holding Since
Dec 2025
2 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in HUMA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Jain Global LLC holds $158,466,048 across 104 Biotechnology names. HUMA ranks #90 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ARGX
Argenx SE
 18,913 $17,546,914
2 ROIV
Roivant Sciences Ltd.
 486,186 $17,206,122
3 ALNY
Alnylam Pharmaceuticals, Inc.
 55,686 $16,763,156
4 MRNA
Moderna, Inc.
 181,264 $12,693,917
5 INSM
INSMED Inc
 111,204 $11,856,570
6 AXSM
Axsome Therapeutics, Inc.
 27,569 $6,748,064
7 MDGL
Madrigal Pharmaceuticals, Inc.
 10,965 $5,887,656
8 ARWR
Arrowhead Pharmaceuticals, Inc.
 61,895 $5,045,061

All Filings in HUMA

Export CSV
2 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $89,355 114,558
2025-12-31 $37,862 39,399